These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 8752157

  • 21. Inhibitors of tyrosine phosphorylation induce apoptosis in human leukemic cell lines.
    Bergamaschi G, Rosti V, Danova M, Ponchio L, Lucotti C, Cazzola M.
    Leukemia; 1993 Dec; 7(12):2012-8. PubMed ID: 8255101
    [Abstract] [Full Text] [Related]

  • 22. Beta-hydroxyisovalerylshikonin induces apoptosis in human leukemia cells by inhibiting the activity of a polo-like kinase 1 (PLK1).
    Masuda Y, Nishida A, Hori K, Hirabayashi T, Kajimoto S, Nakajo S, Kondo T, Asaka M, Nakaya K.
    Oncogene; 2003 Feb 20; 22(7):1012-23. PubMed ID: 12592388
    [Abstract] [Full Text] [Related]

  • 23. Detection of apoptosis induced by topoisomerase inhibitors and serum deprivation in syrian hamster embryo cells.
    Alexandre S, Rast C, Nguyen-Ba G, Vasseur P.
    Exp Cell Res; 2000 Feb 25; 255(1):30-9. PubMed ID: 10666331
    [Abstract] [Full Text] [Related]

  • 24. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G, Chang BS, Kim CN, Perkins C, Thompson CB, Bhalla KN.
    Cancer Res; 1998 Aug 01; 58(15):3202-8. PubMed ID: 9699642
    [Abstract] [Full Text] [Related]

  • 25. [Apoptosis of human leukemic cells induced by topoisomerase I and II inhibitors].
    Solary E, Dubrez L, Eymin B, Bertrand R, Pommier Y.
    Bull Cancer; 1996 Mar 01; 83(3):205-12. PubMed ID: 8695922
    [Abstract] [Full Text] [Related]

  • 26. Intracellular Ca2+ release mediates ursolic acid-induced apoptosis in human leukemic HL-60 cells.
    Baek JH, Lee YS, Kang CM, Kim JA, Kwon KS, Son HC, Kim KW.
    Int J Cancer; 1997 Nov 27; 73(5):725-8. PubMed ID: 9398053
    [Abstract] [Full Text] [Related]

  • 27. Topoisomerase inhibitor camptothecin sensitizes mouse hepatocytes in vitro and in vivo to TNF-mediated apoptosis.
    Hentze H, Latta M, Künstle G, Dhakshinamoorthy S, Ng PY, Porter AG, Wendel A.
    Hepatology; 2004 May 27; 39(5):1311-20. PubMed ID: 15122760
    [Abstract] [Full Text] [Related]

  • 28. Activation of chymotrypsin-like serine protease(s) during apoptosis detected by affinity-labeling of the enzymatic center with fluoresceinated inhibitor.
    Grabarek J, Dragan M, Lee BW, Johnson GL, Darzynkiewicz Z.
    Int J Oncol; 2002 Feb 27; 20(2):225-33. PubMed ID: 11788882
    [Abstract] [Full Text] [Related]

  • 29. Evidence that non-caspase proteases are required for chromatin degradation during apoptosis.
    Hughes FM, Evans-Storms RB, Cidlowski JA.
    Cell Death Differ; 1998 Dec 27; 5(12):1017-27. PubMed ID: 9894608
    [Abstract] [Full Text] [Related]

  • 30. The ATM protein is required for sustained activation of NF-kappaB following DNA damage.
    Piret B, Schoonbroodt S, Piette J.
    Oncogene; 1999 Apr 01; 18(13):2261-71. PubMed ID: 10327072
    [Abstract] [Full Text] [Related]

  • 31. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
    Goldwasser F, Bae I, Fornace AJ, Pommier Y.
    Oncol Res; 1996 Apr 01; 8(7-8):317-23. PubMed ID: 8938795
    [Abstract] [Full Text] [Related]

  • 32. Differential effect of camptothecin treatment on topoisomerase II alpha expression in ML-1 and HL-60 leukemia cell lines.
    Nair J, Traganos F, Tse-Dinh YC.
    Anticancer Res; 2000 Apr 01; 20(6B):4183-8. PubMed ID: 11205246
    [Abstract] [Full Text] [Related]

  • 33. Sorafenib induces apoptosis in HL60 cells by inhibiting Src kinase-mediated STAT3 phosphorylation.
    Zhao W, Zhang T, Qu B, Wu X, Zhu X, Meng F, Gu Y, Shu Y, Shen Y, Sun Y, Xu Q.
    Anticancer Drugs; 2011 Jan 01; 22(1):79-88. PubMed ID: 20881478
    [Abstract] [Full Text] [Related]

  • 34. Ajoene, an experimental anti-leukemic drug: mechanism of cell death.
    Dirsch VM, Antlsperger DS, Hentze H, Vollmar AM.
    Leukemia; 2002 Jan 01; 16(1):74-83. PubMed ID: 11840266
    [Abstract] [Full Text] [Related]

  • 35. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.
    Dubrez L, Goldwasser F, Genne P, Pommier Y, Solary E.
    Leukemia; 1995 Jun 01; 9(6):1013-24. PubMed ID: 7596166
    [Abstract] [Full Text] [Related]

  • 36. NF-kappaB pathway is involved in griseofulvin-induced G2/M arrest and apoptosis in HL-60 cells.
    Uen YH, Liu DZ, Weng MS, Ho YS, Lin SY.
    J Cell Biochem; 2007 Aug 01; 101(5):1165-75. PubMed ID: 17226769
    [Abstract] [Full Text] [Related]

  • 37. Purification and characterization of a Mg2+-dependent endonuclease (AN34) from etoposide-treated human leukemia HL-60 cells undergoing apoptosis.
    Yoshida A, Pourquier P, Pommier Y.
    Cancer Res; 1998 Jun 15; 58(12):2576-82. PubMed ID: 9635581
    [Abstract] [Full Text] [Related]

  • 38. 7-Hydroxystaurosporine (UCN-01) induces apoptosis in human colon carcinoma and leukemia cells independently of p53.
    Shao RG, Shimizu T, Pommier Y.
    Exp Cell Res; 1997 Aug 01; 234(2):388-97. PubMed ID: 9260909
    [Abstract] [Full Text] [Related]

  • 39. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.
    Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG.
    Cancer Res; 1993 Sep 01; 53(17):3976-85. PubMed ID: 8358726
    [Abstract] [Full Text] [Related]

  • 40. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
    Ibrado AM, Huang Y, Fang G, Liu L, Bhalla K.
    Cancer Res; 1996 Oct 15; 56(20):4743-8. PubMed ID: 8840993
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.